Market World In-vitro Toxicology Testing Market Analysis | Page 2

innovative methods. Alternative methods such as computer models, cells & tissue cultures, and alternative
organism which can substitute animal studies are anticipated to drive the market through to 2025.
Furthermore, the growth of toxicology catalogues for in-silico tests are expected to fuel market progress in the
coming years. Extensive government funding coupled with reimbursement policies for the development of
technologically advanced and automated instruments for ex-vivo and laboratory analysis is predicted to
augment market stability. However, unavailability of immune stimulation and immune testing are anticipated
to obstruct the growth to certain extent.
Method Insights
The largest share of market revenue was accounted by cellular assay due to the availability of in-vitro toxicology
techniques for pharmacokinetic reporting. Moreover, nowadays’ early detection of toxicity in the drug
development process is the trend which is an important parameter mandatory for human cell-based in-vitro
prototypes.
Technology Insights
The largest share of revenue was accounted by cell culture technology due to significant improvement in cell
line production and cell culture techniques. Moreover, forthcoming advances in genome sequencing field
affecting to toxicology analysis are the factors which are anticipated to drive industrial progress.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/in-vitro-toxicology-testing-market
Application Insights
Systemic Toxicology is the major application which contributes in revenue generation to the largest extent
because of higher preference by clinicians for intravascular drugs administration which boosts systemic toxicity
to relatively larger extent.
Dermal toxicity is expected to register substantial growth in the coming years. Side-effects of products on skin
and drug-drug interactions are the factors that drive this market through to 2025.
End-use Insights
In 2016, the largest share of approximately 35% was accounted by pharmaceuticals due to application of such
studies for analysis of generic modified and innovative products are high in pharmaceutics.